Search Results - S. V. Liu
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
Tracking the tail by Alex Friedlaender, Alfredo Addeo, Stephen V Liu
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
2
-
3
-
4
-
5
-
6
-
7
Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab by Reyes Bernabé, Stephen V. Liu, Amparo Sánchez-Gastaldo, Miriam Alonso García
Published in Oncology and Therapy (2024-01-01)Get full text
Article -
8
Real-world survival of patients treated with taxane therapy after exposure to immunotherapy and platinum-based chemotherapy for advanced non-small-cell lung cancer without actionab... by S.V. Liu, X. Hu, D. Chirovsky, W. Meng, A. Samkari
Published in ESMO Real World Data and Digital Oncology (2024-03-01)Get full text
Article -
9
-
10
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung by Giuseppe Esposito, Giuseppe Giaccone, Chul Kim, Stephen V Liu, Deepa S Subramaniam, Tisdrey Torres, Massimo Loda
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
11
Drugging KRAS: current perspectives and state-of-art review by Kaushal Parikh, Giuseppe Banna, Stephen V. Liu, Alex Friedlaender, Aakash Desai, Vivek Subbiah, Alfredo Addeo
Published in Journal of Hematology & Oncology (2022-10-01)Get full text
Article -
12
A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer by Deepa S. Subramaniam, Stephen V. Liu, Jeanette Crawford, Jenna Kramer, Jillian Thompson, Hongkun Wang, Giuseppe Giaccone
Published in Frontiers in Oncology (2018-03-01)Get full text
Article -
13
Epigenetic Therapy in Lung Cancer by Stephen V Liu, Muller eFabbri, Muller eFabbri, Barbara J. Gitlitz, Ite A. Laird-Offringa
Published in Frontiers in Oncology (2013-05-01)Get full text
Article -
14
Real-World Outcomes of First-Line Treatment With Anti–PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in Europe... by Stephen V. Liu, Anandaroop Dasgupta, Dominick Latremouille-Viau, Carmine Rossi, Pragya Rai, Fabrice Barlesi, Ticiana A. Leal
Published in JCO Global Oncology (2024-09-01)Get full text
Article -
15
791 Treatment patterns and real-world clinical outcomes of first-line anti-PD(L)1-based combination therapy among patients with non-squamous metastatic non-small cell lung cancer i... by Carmine Rossi, Fabrice Barlesi, Stephen V Liu, Ticiana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, Pragya Rai
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
16
Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in... by Ticiana A. Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, Carmine Rossi, Pragya Rai, Fabrice Barlesi, Stephen V. Liu
Published in JCO Global Oncology (2024-03-01)Get full text
Article -
17
Large animal model species in pluripotent stem cell therapy research and development for retinal diseases: a systematic review by Julia-Sophia Bellingrath, Kang V. Li, Kanza Aziz, Jessica M. Izzi, Ying V. Liu, Mandeep S. Singh, Mandeep S. Singh
Published in Frontiers in Ophthalmology (2024-08-01)Get full text
Article -
18
Understanding and Modeling the Dynamics of Storm‐Time Atmospheric Neutral Density Using Random Forests by K. Murphy, A. J. Halford, V. Liu, J. Klenzing, J. Smith, K. Garcia‐Sage, J. Pettit, I. J. Rae
Published in Space Weather (2025-01-01)Get full text
Article -
19
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer by Sanjay Popat, Stephen V. Liu, Nicolas Scheuer, Grace G. Hsu, Alexandre Lockhart, Sreeram V. Ramagopalan, Frank Griesinger, Vivek Subbiah
Published in Nature Communications (2022-06-01)Get full text
Article -
20
First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices by Stephen V. Liu, MD, Pragya Rai, PhD, Dong Wang, PhD, Xiaohan Hu, PhD, MPH, Paul Otto Schwarzenberger, MD
Published in JTO Clinical and Research Reports (2023-02-01)Get full text
Article
